Greater Disease Severity and Reduced Quality of Life are Not Associated With Treatment Adherence in Atopic Patients With Xerosis

J Cutan Med Surg. 2023 Sep-Oct;27(5):534-536. doi: 10.1177/12034754231188435. Epub 2023 Jul 26.

Authors

Christina Kontzias¹, Stuti Prajapati², Steven R Feldman^{1

2

3}

Affiliations

¹ Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
² Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
³ Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.

PMID: 37493272
DOI: 10.1177/12034754231188435

No abstract available

Keywords: DLQI; adherence; disease burden; quality of life; topical therapy; xerosis.

Publication types

Letter

MeSH terms

Dermatitis, Atopic* / complications
Dermatitis, Atopic* / drug therapy
Humans
Patient Acuity
Quality of Life*
Severity of Illness Index
Treatment Adherence and Compliance